BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38336973)

  • 1. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
    Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
    Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity.
    El Bolkainy TM; Abo Deif WS; Gouda HM; Mokhtar NM
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):17-30. PubMed ID: 19847278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration.
    Swart L; Novitzky N; Mohamed Z; Opie J
    Ann Hematol; 2019 Feb; 98(2):381-389. PubMed ID: 30397846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic and Prognostic Value of
    Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
    Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C
    Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.
    Wang Y; Xie L; Tian R; Deng Y; Zhang W; Zou L; Zhang H; Liu J; Zhao S; Ding W; Liu W; Jiang M
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2529-2539. PubMed ID: 31485768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases.
    Büyükşimşek M; Kolsuz İ; Yetişir AE; Tohumcuoğlu M; Oğul A; Mirili C; Paydaş S; Güney İB
    Turk J Haematol; 2020 Nov; 37(4):220-225. PubMed ID: 32003552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
    Ródenas-Quiñonero I; Chen-Liang T; Martín-Santos T; Salar A; Fernández-González M; Celades C; Navarro JT; Martínez-Garcia AB; Andreu R; Balaguer A; Martin García-Sancho A; Baile M; López-Jiménez J; Marquet-Palomanes J; Teruel AI; Terol MJ; Benet C; Frutos L; Navarro JL; Uña J; Suarez M; Cortes M; Contreras J; Ruiz C; Tamayo P; Mucientes J; Sopena-Novales P; Reguilón-Gallego L; Sánchez-Blanco JJ; Pérez-Ceballos E; Jerez A; Ortuño FJ
    Cancer Med; 2023 Mar; 12(6):6536-6546. PubMed ID: 36373169
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
    Rutherford SC; Yin J; Pederson L; Perez Burbano G; LaPlant B; Shadman M; Li H; LeBlanc ML; Kenkre VP; Hong F; Blum KA; Dockter T; Martin P; Jung SH; Grant B; Rosenbaum C; Ujjani C; Barr PM; Unger JM; Cheson BD; Bartlett NL; Kahl B; Friedberg JW; Mandrekar SJ; Leonard JP
    J Clin Oncol; 2023 Jan; 41(2):336-342. PubMed ID: 35787017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study.
    Alzahrani M; El-Galaly TC; Hutchings M; Hansen JW; Loft A; Johnsen HE; Iyer V; Wilson D; Sehn LH; Savage KJ; Connors JM; Gascoyne RD; Johansen P; Clasen-Linde E; Brown P; Villa D
    Ann Oncol; 2016 Jun; 27(6):1095-1099. PubMed ID: 27002106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma.
    Ke Q; Liao CC; Tan XH; Guo BP; Cen H; Li LQ
    PLoS One; 2021; 16(5):e0252226. PubMed ID: 34043683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
    Puccini B; Nassi L; Minoia C; Volpetti S; Ciancia R; Riccomagno PC; Di Rocco A; Mulè A; Toldo C; Sassone MC; Guariglia R; Filì C; Finolezzi E; Falorio S; Zanon S; Furlan A; Doa G; Zaja F;
    Ann Hematol; 2017 Jul; 96(7):1147-1153. PubMed ID: 28451805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset.
    Luan D; Wu Y; Goldstein J; Rutherford S; Leonard JP; Martin P
    Leuk Lymphoma; 2021 Aug; 62(8):1850-1859. PubMed ID: 33627025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for and outcomes after bone marrow biopsy in Scandinavian patients with chronic immune thrombocytopenia.
    Gotschalck MA; Nørgaard M; Risbo N; Christiansen CF; Bahmanyar S; Ghanima W; Alam N; Frederiksen H; Nielson CM; Sørensen HT
    Eur J Haematol; 2021 Jul; 107(1):145-156. PubMed ID: 33851445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
    Kaddu-Mulindwa D; Altmann B; Held G; Angel S; Stilgenbauer S; Thurner L; Bewarder M; Schwier M; Pfreundschuh M; Löffler M; Menhart K; Grosse J; Ziepert M; Herrmann K; Dührsen U; Hüttmann A; Barbato F; Poeschel V; Hellwig D
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3550-3559. PubMed ID: 33928400
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.